A new clinical trial is exploring better treatment options for young women with the most common form of breast cancer. The OLIO trial builds on earlier research that identified a unique tumour feature in premenopausal women with hormone receptor (HR) positive, HER2 negative breast cancer - a subtype that can be more aggressive in younger women. OLIO is investigating whether targeted therapy with olaparib, or olaparib combined with durvalumab, added to standard chemotherapy before surgery, can mo

330K views · 807 reactions | Should we ban the bell-ringing ceremonies which celebrate the end of cancer treatment? Last month one bell was removed by a hospital because it was deemed ‘cruel’ to others still undergoing their own treatment. Jane Cubbin’s son was able to ring the end of treatment bell and said it gave him great hope, but Jo Taylor, a cancer patient herself, thinks the bell should be removed. | This Morning | Facebook

2.7K views · 340 reactions | Do the benefits of the vaccine outweigh the side effects? Take a look at what community leaders, scientists, and health workers in the Western Cape have to say. Get informed with accurate information to make the right choice for you! Go to https://vaccine.enroll.health.gov.za/#/ to register for the vaccine online. #staysafemoveforward #letsdothis | Safely Home by Western Cape Government | Facebook

198K views · 1.4K reactions | Johann Hari They’re Lying To You About The Side Effects Of Ozempic! - The Diary Of A CEO | The Diary Of A CEO | Facebook